IBB 151.00 ▲ 0.92% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NASDAQ: IBB · Real-Time Price · USD
    151.00
    1.38 (0.92%)
    At close: Oct 03, 2025, 3:59 PM
    151.05
    0.03%
    Pre-market: Oct 06, 2025, 05:19 AM EDT
    0.92%
    Bid 146.46
    Market Cap 5.8B
    Revenue (ttm) n/a
    Net Income (ttm) n/a
    EPS (ttm) 6.7970867
    PE Ratio (ttm) 22.22
    Forward PE n/a
    Analyst n/a
    Dividends n/a
    Ask 154.59
    Volume 3,409,373
    Avg. Volume (20D) 1,694,685
    Open 150.32
    Previous Close 149.62
    Day's Range 149.82 - 151.63
    52-Week Range 107.43 - 151.62
    Beta n/a
    Ex-Dividend Date n/a

    About IBB

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol IBB
    Website n/a
    Full Company Profile
    news image

    3 weeks ago · benzinga.com

    Trump's Biotech Playbook Ignites $350 Billion Investment Blitz

    Biotech is back – and it's playing for keeps. President Donald Trump's second-term policies have unleashed a staggering ~$350 billion surge in U.S.-based pharmaceutical and biotech investments, from d...

    1 month ago · youtube.com

    Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

    Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.

    news image

    1 month ago · seekingalpha.com

    BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH

    Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators wit...

    news image

    1 month ago · zacks.com

    Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

    A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.

    news image

    1 month ago · zacks.com

    Should You Invest in the iShares Biotechnology ETF (IBB)?

    Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on Febru...

    2 months ago · youtube.com

    Trump's deadline looms for Big Pharma companies facing new tariffs

    'The Big Money Show' panel discusses President Donald Trump's pharmaceutical tariff strategy.

    2 months ago · youtube.com

    Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

    However, the President did not disclose when the tariffs would take effect.

    news image

    3 months ago · seekingalpha.com

    Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

    IBB and XBI are similar in many ways, but their relative past performance does not tell the story. IBB is more concentrated, and that is ultimately why I prefer it to XBI. Both ETFs target a similar o...

    Add to Watchlist